Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 11:46 PM
Study NCT ID:
NCT03435094
Status:
UNKNOWN
Last Update Posted:
2020-12-03
First Post:
2018-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
Sponsor:
Labatec Pharma SA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-01
First Submit QC Date:
None
Study First Post Date:
2018-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-01
Last Update Post Date:
2020-12-03
Last Update Post Date Type:
ACTUAL